|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Excess toxicity Associated
with Docetaxel and Irinotecan in Patients with Metastatic, Gemcitabine-Refractory
Pancreatic Cancer: Results of a Phase II Study Cancer Invest. 2008 Feb;26(1):47-52.
PMID: 18181045 |
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |